ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...
SAN FRANCISCO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading software and analytics company for cell and gene therapies, today announced that it will be expanding its technology ...
Zacks Investment Research on MSN
IBRX stock jumps on progress in NK cell therapy production
Shares of ImmunityBio IBRX rose more than 7% on Friday after the company announced that it completed two manufacturing ...
The company also welcomes new board member and industry expert Cyrus K. Mirsaidi in furthering Sanguine's mission to integrate patients into the therapeutic research and development process. Human ...
Immunocytochemical (ICC) analysis was carried out using previously published methods 15 to detect polypeptide components of structural proteins, cytokeratins (CK), comprising the epithelial cell ...
LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT launched the Correct Connect System, a new, standardized connection system for the solutions used during apheresis procedures. The Correct Connect system ...
Germline variants in cancer risk genes detected by NGS-based comprehensive tumor genomic profiling (CGP). This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果